Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer

NCT00003906 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00003906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Lead sponsor
NSABP Foundation Inc
Phase
Phase 3
Overall status
Completed
Start date
May 31, 1999
Completion date
August 31, 2012
Enrollment
19,747 (actual)
Sites
516

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer